{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐608 (miR-608) has emerged as a potent tumor suppressor in a variety of cancers. In chordomas, its downregulation promotes malignant behavior through loss of repression of oncogenic factors such as EGFR and Bcl-xL, while restoration of miR-608 expression inhibits proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In colon cancer, miR-608 targets NAA10 mRNA to decrease cell-cycle progression and promote apoptosis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ", and in glioma stem cells, it directly represses MIF, thereby reducing the aggressive properties of these cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Similarly, in lung adenocarcinoma, overexpression of miR-608 induces cell death, an effect that is reversible upon its inhibition"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "; in hepatocellular carcinoma, miR-608 suppresses cell proliferation via the downregulation of BRD4"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "; in prostate cancer, it limits cell proliferation and invasion by modulating the RAC2/PAK4/LIMK1/cofilin and BCL2L1/caspase-3 pathways"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "; and in non-small cell lung cancer its increased expression enhances cisplatin sensitivity through repression of TEAD2."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In gastric cancer, competing endogenous RNA interactions reveal that miR-608, when sequestered by the lncRNA NORAD, normally functions to downregulate FOXO6, thereby curbing tumor growth."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In colon cancer patients treated with 5-fluorouracil-based chemotherapy, specific MIR608 polymorphisms were also associated with a decreased risk of relapse"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and in lung adenocarcinoma patients undergoing EGFR-tyrosine kinase inhibitor therapy, MIR608 variants significantly predicted improved progression-free and overall survival, confirming its role in modulating treatment response."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its direct tumor-suppressive actions, genetic variations within miR-608—most notably the rs4919510 single nucleotide polymorphism—have been evaluated as predictive biomarkers for cancer risk and prognosis. In nasopharyngeal carcinoma, the rs4919510 variant is associated with a higher rate of locoregional recurrence following radiotherapy"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": ", while investigations in colorectal cancer suggest that this polymorphism may modulate susceptibility."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " In locally advanced rectal cancer, patients bearing the G allele of rs4919510 exhibited a decreased risk of relapse when treated with adjuvant chemotherapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Moreover, meta-analyses have revealed that the association between rs4919510 and cancer risk appears to be type-specific—correlating with increased risk in some tumors (e.g., papillary thyroid and gastric cancers) and a decreased risk in colorectal cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ";"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": " In hepatocellular carcinoma, the rs4919510 CC genotype is linked to prolonged overall survival"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", and in breast cancer, pooled analyses have further underscored the prognostic potential of MIR608 variants."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Evidence from studies in musculoskeletal injury also hints at a borderline association of rs4919510 with Achilles tendinopathy"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", reinforcing the notion that MIR608 genetic variants serve as useful biomarkers for patient stratification.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer, miR-608 also plays important roles in regulating inflammatory and immune responses. It directly targets acetylcholinesterase, which in turn modulates downstream mediators such as CDC42 and interleukin-6, linking its function to the regulation of neuromodulatory and inflammatory signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": " Additionally, miR-608 is implicated in controlling the expression of HLA-G by binding to polymorphic regions on its 3'-UTR, potentially affecting immune tolerance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " In human monocytes, miR-608 regulates the expression of neutrophil elastase (ELANE), further underscoring its role as a critical post-transcriptional regulator in inflammatory processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": " Moreover, studies in esophageal squamous cell carcinoma highlight an association between circulating IL-6 levels and miR-608 polymorphisms, while research in idiopathic pulmonary fibrosis suggests that miR-608—with its unique primate specificity—may contribute to disease pathology via targets such as CDC42 and IL-6"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": ";."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional regulatory functions of miR-608 have been delineated through its binding to specific cis-acting elements. For instance, a functional miR-608 binding site has been identified within the 3'-UTR of COL5A1, where it may influence mRNA secondary structure and the stability of transcripts involved in connective tissue integrity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": " Moreover, studies in Kawasaki disease have explored the association between the miR-608 rs4919510 polymorphism and disease susceptibility, suggesting that miR-608 may also impact inflammatory vascular conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": " Collectively, these findings underscore the multifunctional nature of miR-608 as both a direct regulator of oncogenic and inflammatory pathways and a potential diagnostic and prognostic biomarker in a spectrum of human diseases.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ying Zhang, David Schiff, Deric Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0091546"}], "href": "https://doi.org/10.1371/journal.pone.0091546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24621885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24621885"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hongju Yang, Qian Li, Jie Niu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6458"}], "href": "https://doi.org/10.18632/oncotarget.6458"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26646451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26646451"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhenhua Wang, Yixue Xue, Ping Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.4652"}], "href": "https://doi.org/10.3892/or.2016.4652"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26935642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26935642"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Norahayu Othman, Lionel L A In, Jennifer A Harikrishna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0081735"}], "href": "https://doi.org/10.1371/journal.pone.0081735"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24339958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24339958"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ling He, Dijuan Meng, Shi-Hu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.05.108"}], "href": "https://doi.org/10.1016/j.bbrc.2018.05.108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29777702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29777702"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xu Zhang, Jiajie Fang, Shiming Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2455"}], "href": "https://doi.org/10.1002/cam4.2455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31389670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31389670"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yanli Wang, Fengcai Li, Dandan Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA‑608 sensitizes non‑small cell lung cancer cells to cisplatin by targeting TEAD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2019.10616"}], "href": "https://doi.org/10.3892/mmr.2019.10616"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31485614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31485614"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zhigang Miao, Xiaozhong Guo, Liang Tian "}, {"type": "b", "children": [{"type": "t", "text": "The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2018.11.052"}], "href": "https://doi.org/10.1016/j.gene.2018.11.052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30453063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30453063"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Barbara Pardini, Fabio Rosa, Alessio Naccarati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgu224"}], "href": "https://doi.org/10.1093/carcin/bgu224"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25368035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25368035"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Nasha Zhang, Yankang Li, Yan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41374-018-0164-y"}], "href": "https://doi.org/10.1038/s41374-018-0164-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30552364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30552364"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jian Zheng, Jieqiong Deng, Mang Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-0395"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-0395"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23796562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23796562"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Bríd M Ryan, Andrew C McClary, Nicola Valeri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0036306"}], "href": "https://doi.org/10.1371/journal.pone.0036306"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22606253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22606253"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Francesco Sclafani, Ian Chau, David Cunningham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgw073"}], "href": "https://doi.org/10.1093/carcin/bgw073"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27381831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27381831"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shuangshuang Wu, Weiyan Yuan, Yu Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317703819"}], "href": "https://doi.org/10.1177/1010428317703819"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28653886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28653886"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Huiquan Liu, Yaqun Zhou, Qingquan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9509"}], "href": "https://doi.org/10.18632/oncotarget.9509"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27223084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27223084"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhi-Ming Dai, Jian-Rui Lv, Kang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.101476"}], "href": "https://doi.org/10.18632/aging.101476"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29909406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29909406"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xiaoqi Zhu, Yichen Liu, Jingsheng Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-608 rs4919510 Polymorphism May Affect Susceptibility to Colorectal Cancer by Upregulating "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "MRPL43"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2020.5689"}], "href": "https://doi.org/10.1089/dna.2020.5689"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33147064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33147064"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiao-Pin Ma, Guopeng Yu, Xubo Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-4897-1"}], "href": "https://doi.org/10.1007/s13277-016-4897-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26815502"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26815502"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jing Wang, Xiangyi Kong, Zeyu Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0183012"}], "href": "https://doi.org/10.1371/journal.pone.0183012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28829821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28829821"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Geula Hanin, Shani Shenhar-Tsarfaty, Nadav Yayon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Competing targets of microRNA-608 affect anxiety and hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddu170"}], "href": "https://doi.org/10.1093/hmg/ddu170"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24722204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24722204"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Iane O P Porto, Celso T Mendes-Junior, Leandro P Felício, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molimm.2015.01.030"}], "href": "https://doi.org/10.1016/j.molimm.2015.01.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25700346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25700346"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Wei Gu, Dalin Wen, Hongxiang Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-608 Exerts Anti-inflammatory Effects by Targeting ELANE in Monocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10875-019-00702-8"}], "href": "https://doi.org/10.1007/s10875-019-00702-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31749032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31749032"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Pei-Wen Yang, Pei-Ming Huang, Luo-Sheng Yong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1245/s10434-018-6532-4"}], "href": "https://doi.org/10.1245/s10434-018-6532-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29948421"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29948421"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Gali Epstein Shochet, Lilach Israeli-Shani, Isabelle Kains, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Pulm Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12890-020-01377-3"}], "href": "https://doi.org/10.1186/s12890-020-01377-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33402146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33402146"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yoonus Abrahams, Mary-Jessica Laguette, Sharon Prince, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms within the COL5A1 3'-UTR that alters mRNA structure and the MIR608 gene are associated with Achilles tendinopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Hum Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/ahg.12013"}], "href": "https://doi.org/10.1111/ahg.12013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23347277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23347277"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yanfei Wang, Zhaoliang Lu, Lanyan Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miRNA-608"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181660"}], "href": "https://doi.org/10.1042/BSR20181660"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31043452"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31043452"}]}]}]}